About 3'(2'),5'-bisphosphate nucleotidase 1
3'(2'),5'-bisphosphate nucleotidase 1 (BPNT1) is a protein
from Homo sapiens identified by UniProt accession
O95861, 308 residues long.
MolForge cross-references it against 0 known binders and
83 disease associations.
Target properties
| Protein name | 3'(2'),5'-bisphosphate nucleotidase 1 |
| UniProt accession | O95861 |
| Gene | BPNT1 |
| Organism | Homo sapiens |
| Length | 308 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (83)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.29
- age at first birth measurement · score 0.16
- mathematical ability · score 0.15
- smoking status measurement · score 0.14
- cortical surface area measurement · score 0.08
- attention deficit hyperactivity disorder · score 0.07
- antisocial behaviour measurement · score 0.07
- substance abuse · score 0.07
- progressive familial intrahepatic cholestasis · score 0.04
- Congenital bile acid synthesis defect type 1 · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O95861-F1 | alphafold | PREDICTED | 96.42 | — |
Amino-acid sequence (308 residues)
MASSNTVLMR LVASAYSIAQ KAGMIVRRVI AEGDLGIVEK TCATDLQTKA DRLAQMSICS SLARKFPKLT IIGEEDLPSE EVDQELIEDS QWEEILKQPC PSQYSAIKEE DLVVWVDPLD GTKEYTEGLL DNVTVLIGIA YEGKAIAGVI NQPYYNYEAG PDAVLGRTIW GVLGLGAFGF QLKEVPAGKH IITTTRSHSN KLVTDCVAAM NPDAVLRVGG AGNKIIQLIE GKASAYVFAS PGCKKWDTCA PEVILHAVGG KLTDIHGNVL QYHKDVKHMN SAGVLATLRN YDYYASRVPE SIKNALVP
Explore 3'(2'),5'-bisphosphate nucleotidase 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets